These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 6676389

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Effect of elcatonin on experimental osteoporosis induced by ovariectomy and low calcium diet in beagles].
    Hori M, Takahashi H, Konno T, Inoue J, Haba T, Sakurada T, Noda T, Fujimoto K.
    Nihon Yakurigaku Zasshi; 1984 Jul; 84(1):91-8. PubMed ID: 6489866
    [Abstract] [Full Text] [Related]

  • 3. Comparison of parathyroid hormone (1-34) and elcatonin in postmenopausal women with osteoporosis: an 18-month randomized, multicenter controlled trial in China.
    Li Y, Xuan M, Wang B, Yang J, Zhang H, Zhang XZ, Guo XH, Lü XF, Xue QY, Yang GY, Ji QH, Liu ZM, Li CJ, Wu TF, Sheng ZY, Li PQ, Tong JC.
    Chin Med J (Engl); 2013 Feb; 126(3):457-63. PubMed ID: 23422107
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A randomized, multicenter controlled trial to compare the efficacy of recombinant human parathyroid hormone (1-34) with elcatonin in postmenopausal women with osteoporosis in China.
    Zhang XZ, Wang B, Yang J, Xuan M, Song LG, Li H, Guo XH, Lü XF, Xue QY, Yang GY, Ji QH, Shen J, Liu ZM, Li CJ, Wu TF, Tong XC, Jia Y.
    Chin Med J (Engl); 2009 Dec 20; 122(24):2933-8. PubMed ID: 20137477
    [Abstract] [Full Text] [Related]

  • 8. Calcium and salmon calcitonin in treatment of osteoporosis.
    Jowsey J, Riggs BL, Kelly PJ, Hoffman DL.
    J Clin Endocrinol Metab; 1978 Sep 20; 47(3):633-9. PubMed ID: 263316
    [Abstract] [Full Text] [Related]

  • 9. Effects of alendronate on plasma calcium levels, urinary calcium excretion, and bone resorption markers in normal rats: comparison with elcatonin, synthetic eel calcitonin.
    Azuma Y, Chokki M, Ohta T, Kiyoki M.
    Endocrinology; 1996 Jun 20; 137(6):2586-92. PubMed ID: 8641213
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of elcatonin in postmenopausal women with osteoporosis: a systematic review with network meta-analysis of randomized clinical trials.
    Chen WC, Lin EY, Kang YN.
    Osteoporos Int; 2019 Sep 20; 30(9):1723-1732. PubMed ID: 31041475
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Additive effect of elcatonin to risedronate for chronic back pain and quality of life in postmenopausal women with osteoporosis: a randomized controlled trial.
    Hongo M, Miyakoshi N, Kasukawa Y, Ishikawa Y, Shimada Y.
    J Bone Miner Metab; 2015 Jul 20; 33(4):432-9. PubMed ID: 25123562
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of the effects of elcatonin and risedronate on back and knee pain by electroalgometry using fall of skin impedance and quality of life assessment using SF-36.
    Fujita T, Ohue M, Nakajima M, Fujii Y, Miyauchi A, Takagi Y.
    J Bone Miner Metab; 2011 Sep 20; 29(5):588-97. PubMed ID: 21455715
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of the drug therapy for established osteoporosis by dual-energy x-ray absorptiometry.
    Shiota E.
    Fukuoka Igaku Zasshi; 1998 Jun 20; 89(6):172-8. PubMed ID: 9695314
    [Abstract] [Full Text] [Related]

  • 16. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
    Onuma E, Azuma Y, Saito H, Tsunenari T, Watanabe T, Hirabayashi M, Sato K, Yamada-Okabe H, Ogata E.
    Clin Cancer Res; 2005 Jun 01; 11(11):4198-203. PubMed ID: 15930357
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.
    Hodsman AB, Fraher LJ, Ostbye T, Adachi JD, Steer BM.
    J Clin Invest; 1993 Mar 01; 91(3):1138-48. PubMed ID: 8450043
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.